Post trial study involving mogamulizumab for treatment of mycosis fungoides and Sezary syndrome. (Abstract Only)
Home / Resource Library / Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial